# A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.

> **NCT00299351** · PHASE2 · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 8 (—)

## Conditions studied

- Peripheral T Cell Lymphoma (PTCL)

## Interventions

- **DRUG:** Depsipeptide

## Key facts

- **NCT ID:** NCT00299351
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 8 (—)
- **Last updated:** 2006-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00299351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00299351, "A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00299351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*